Twist Bioscience Corp (FRA:0ME)
€ 39.22 -1.36 (-3.35%) Market Cap: 2.23 Bil Enterprise Value: 2.04 Bil PE Ratio: 0 PB Ratio: 4.90 GF Score: 83/100

Twist Bioscience Corp at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 01:15AM GMT
Release Date Price: €31.28 (+3.03%)
Martin Roseveare J.P. Morgan;Co.;Analyst

&-

All right, good afternoon, everyone, and thank you for joining us. My name is Martin Roseveare I'm from the Life Science Tools and Diagnostics team here at JPMorgan. It is my pleasure to introduce our next company, Twist Bioscience, just as a reminder, after the presentation, we will have a Q&A and if you're in the audience, want to ask a question, raise your hand and somebody will pass you over to mike, if you're online, you can submit it online your question.

And with that, I will turn it over to the Twist CEO, Emily Leproust.

Emily Leproust Twist Bioscience Corporation;Co;Founder
Chairman & CEO

Thank you very much for the invitation and the introduction. It's my great pleasure to present the Twist story. And I'll start by saying that today I'll be making some forward-looking statements. So for those of you that are new to Twist, we make DNA. We have delivered consistent revenue growth as well as market share expansion and that is really

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot